Roche Revenue and Competitors
Estimated Revenue & Valuation
- Roche's estimated annual revenue is currently $17.5B per year.
- Roche's estimated revenue per employee is $155,000
Employee Data
- Roche has 113115 Employees.
- Roche grew their employee count by 2% last year.
Roche's People
Name | Title | Email/Phone |
---|---|---|
1 | Medical Partner & Product Owner | Reveal Email/Phone |
2 | CEO Roche Group | Reveal Email/Phone |
3 | Business Owner DEX (Digital Employee Experience) - hi site App Basel & Kaiseraugst | Reveal Email/Phone |
4 | Project Leader, Technical SME, Solution Owner | Reveal Email/Phone |
5 | System Owner, Global & Regional People & Culture (HR) Applications | Reveal Email/Phone |
6 | Information Technology Business Partner (Project Manager / Solution Owner) | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | CEO Roche Pharmaceuticals | Reveal Email/Phone |
9 | Chief Staff | Reveal Email/Phone |
10 | Quality Site Head, VP | Reveal Email/Phone |
Roche Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.1M | 80 | 1% | N/A | N/A |
#2 | $120.8M | 593 | N/A | N/A | N/A |
#3 | $69340M | 107310 | 4% | N/A | $308.4B |
#4 | $18.8M | 72 | 14% | N/A | N/A |
What Is Roche?
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our R&D projects are being developed with companion diagnostics.
keywords:N/AN/A
Total Funding
113115
Number of Employees
$17.5B
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Roche News
In this week's Pipeline Moves, we start off with the termination of an investigator-led Phase II cancer study of Roche's asset.
AbbVie is breathing down Roche's neck. Late Wednesday, AbbVie and Genmab shared top-line data on their CD20xCD3 bispecific epcoritamab in 157 patients with...
Headquartered in Basel, Switzerland, Roche is one of the largest biotech companies in the world, providing state-of-the-art diagnostics and...
The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. This is the first time that research scientists can conduct oncology ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $78620M | 211696 | 10% | N/A |